Multimodality imaging to assess immediate response following irreversible electroporation in patients with malignant hepatic tumors

Multimodality imaging to assess immediate response following irreversible electroporation in patients with malignant hepatic tumors
复制标题

DOI:
10.1007/s10396-016-0767-0
复制
发表时间:
2017-07-01
影响因子:
1.8
通讯作者:
Itoi, Takao
Itoi, Takao
中科院分区:
医学4区
文献类型:
--
作者:
Sugimoto, Katsutoshi;Moriyasu, Fuminori;Itoi, Takao

文献摘要

被引文献

相似文献

目的评价超声造影(CEUS)、多期CT增强扫描(CECT)和增强磁共振成像(EOB-MRI)对不可逆电穿孔(IRE)治疗的16例21个肝脏病变的诊断价值。每隔3个月行EOB-MRI或CECT及CEUS随访检查。两位放射科医生独立审查了这些图像,并使用带有受试者工作特征(ROC)曲线分析的五点量表评估了肿瘤残留的可能性。并对其敏感性和特异性进行了评价。结果CEUS的ROC曲线下面积(0.980)显著高于CECT(0.742,P<0.01)和EOB-MRI(0.806,P<0.01)。CEUS的敏感性和特异性分别为85.7%和85.7%,CECT分别为64.3%和46.4%,EOB-MRI分别为78.6%和64.3%。结论CEUS诊断IRE术后亚急性期肿瘤残留优于CECT和EOB-MRI。
Purpose To assess the diagnostic accuracy of contrastenhanced ultrasound (CEUS), contrast-enhanced multiphase CT (CECT), and gadoxetic acid-enhanced MRI (EOB-MRI) in identifying residual tumor in the subacute follow-up of patients with malignant hepatic tumors treated by irreversible electroporation (IRE).Methods We enrolled 16 patients with 21 hepatic lesions treated by IRE and examined by CEUS and CECT at 1 day after IRE and by EOB-MRI at 7 days after IRE. Follow-up examinations by EOB-MRI or CECT and CEUS were performed at 3-month intervals. Two radiologists independently reviewed the images and assessed the probability of residual tumor using a five-point scale with receiver operating characteristic (ROC) curve analysis. The sensitivity and specificity were also evaluated. Verifiable local recurrence was assessed using follow-up imaging as the reference standard.Results The mean area under the ROC curve was significantly higher for CEUS (0.980) than for CECT (0.742, P < 0.01) and EOB-MRI (0.806, P < 0.01), as were the sensitivity and specificity (mean 85.7 and 85.7% for CEUS, respectively, vs 64.3 and 46.4% for CECT and 78.6 and 64.3% for EOB-MRI).Conclusion CEUS was found to be superior to CECT and EOB-MRI for the diagnosis of residual tumor in the subacute phase following IRE.